In the current case series, daptomycin was shown to be a safe and effective therapeutic option in the management of VRE UTIs. Because of the increasing prevalence of VRE infection and the limited ...

The risk for treatment failure and hospital readmission was lower among patients with MSSI BSIs who received high- vs standard-dose daptomycin as OPAT after discharge.

Background: This subgroup analysis of the European Cubicin Outcomes Registry Experience evaluated the safety and effectiveness of daptomycin in children and adolescent patients (<18 years).